1211.HK
2015.HK
9866.HK

Electric vehicle (EV) makers Nio Inc. (NIO.US; 9866.HK) and BYD Co. Ltd. (1211.HK; 002594.SZ) reported strong double-digit sales gains in January, but Li Auto Inc. (LI.US; 2015.HK) stumbled during the month with a sales decline, according to data published by the three on Sunday.

BYD said its new energy vehicle (NEV) deliveries rose 59% year-on-year to 327,864 in January, while Nio said its sales for the month rose 38% to 13,863. But Li Auto reported a slight decline for the month, saying its EV deliveries fell about 4% to 29,927 in January this year from 31,165 in the same month of 2024.

Sales for EV makers are often tied to the release of new models, with many companies often posting strong gains in the first few months after such new models go on sale.

China is the world’s largest NEV market, with sales up 40% last year to nearly 11.6 million units. Chinese NEV makers also exported 1.3 million units last year, up 6.7% year-on-year, but are facing growing resistance in major markets like the U.S. and Europe that accuse the companies of receiving unfair state support.

Of the major Chinese EV brands, only BYD and Li Auto are consistently profitable. Hong Kong-listed shares of BYD were down 0.5% midway through the trading day on Monday, the first trading day after the long Chinese New Year holiday. Li Auto’s Hong Kong-listed shares were down 6.5% midway through the day, while Nio’s Hong Kong shares were down 2.9%.

By Doug Young

To subscribe to Bamboo Works free weekly newsletter, click here

Recent Articles

Illustration of Luckin and Costa coffee being tasted

Luckin Coffee eyes global leap as China’s Double 11 loses its luster

Luckin could be preparing a bid for Costa Coffee. What's driving this potential deal, and what are its chances for success? And this year's Double 11 festival looks like a dud, with most big e-commerce companies failing to publish any big numbers. What does the future hold for this fast-fading shopping fest?
So-Young runs cosmetic surgery clinics

Can So-Young find new youth in bricks and mortar?

The cosmetic surgery specialist’s top line is growing as it opens new ‘light medical aesthetic’ clinics, but its bottom line is sagging as its older platform business evaporates Key Takeaways:…
CSPC delivered lower nine-month revenues and profits

CSPC feels the pain from sweeping cuts in drug prices

The pharmaceutical giant is paying the price for its aggressively low bids in China’s centralized drug tenders, as it shifts its focus from traditional to novel drugs Key Takeaway: The…